LUCID Partners With Japanese Pharmaceutical Company to Develop Personalized Music Treatment for Alzheimer's Disease
yahoo.com
news
2022-06-02 20:09:00

Alzheimer's Digital Therapeutic to Unlock the Power of Music Therapy

TORONTO, June 02, 2022--(BUSINESS WIRE)--12.7 million Americans aged 65 and older are projected to have Alzheimer's dementia by 2050. LUCID and JT are now partnering on the development of a prescription digital therapeutic for Alzheimer's disease.

Alzheimer's is more than just memory loss â€“ neuropsychiatric symptoms can include anxiety, aggression and personality changes. These symptoms aren't just heartbreaking, they're promoting the burnout of caregivers.
